What is the value for microalbuminemia, defined as an abnormal albumin-to-creatinine ratio (ACR) in a urine sample?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Microalbuminuria is defined as an albumin-to-creatinine ratio (ACR) of 30-300 mg/g in a urine sample. This range represents an abnormal amount of albumin excretion that exceeds normal levels but falls below the threshold for clinical proteinuria. Values below 30 mg/g are considered normal, while values above 300 mg/g indicate macroalbuminuria or overt proteinuria. Microalbuminuria serves as an important early marker of kidney damage, particularly in conditions like diabetes and hypertension, where it can precede clinically significant kidney disease by several years. The presence of microalbuminuria indicates damage to the glomerular filtration barrier, allowing small amounts of albumin to leak into the urine. Early detection through routine screening enables timely intervention with medications like ACE inhibitors or ARBs to slow progression of kidney disease and reduce cardiovascular risk, as microalbuminuria is also associated with increased cardiovascular morbidity and mortality 1.

Some key points to consider:

  • Microalbuminuria is a well-established marker of increased cardiovascular risk 1.
  • The definition of microalbuminuria is based on an albumin-to-creatinine ratio (ACR) of 30-300 mg/g in a urine sample 1.
  • Values below 30 mg/g are considered normal, while values above 300 mg/g indicate macroalbuminuria or overt proteinuria 1.
  • Microalbuminuria can be measured from spot urine samples, and the first morning spot urine sample is preferred 1.
  • At least two of three tests measured within a 6-month period should show elevated levels before a patient is designated as having microalbuminuria 1.

It is essential to note that the presence of microalbuminuria indicates damage to the glomerular filtration barrier, allowing small amounts of albumin to leak into the urine. Early detection through routine screening enables timely intervention with medications like ACE inhibitors or ARBs to slow progression of kidney disease and reduce cardiovascular risk.

From the Research

Definition of Microalbuminemia

Microalbuminemia is defined as an abnormal albumin-to-creatinine ratio (ACR) in a urine sample. The normal values for ACR are:

  • Less than 2.5 mg/mmol for males 2
  • Less than 3.5 mg/mmol for females 2

Values for Microalbuminemia

The values for microalbuminemia are:

  • 2.5 to 25 mg/mmol for males 2
  • 3.5 to 35 mg/mmol for females 2
  • 30-300 mg/day or 20-200 microg/min 2, 3
  • ACR of 0.03 mg/mg or higher suggests microalbuminuria 3

Screening for Microalbuminemia

Screening for microalbuminemia can be done using:

  • Albumin excretion rate (AER) in a timed urine sample (gold standard) 4
  • Albumin:creatinine ratio in a random or first morning urine sample 5, 4
  • Total urine protein-to-creatinine ratio (TPCR) as an alternative method 6

Prediction of Microalbuminemia

The total-protein-to-creatinine ratio can predict the presence of microalbuminuria in patients with diabetic nephropathy, with a significant correlation between urine total-protein-to-creatinine ratio and urine albumin to creatinine ratio (R2 = 0.824) 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Microalbuminuria: what is it? Why is it important? What should be done about it?

Journal of clinical hypertension (Greenwich, Conn.), 2001

Research

Screening for microalbuminuria: which measurement?

Diabetic medicine : a journal of the British Diabetic Association, 1991

Research

Screening for early diabetic nephropathy.

Annals of clinical biochemistry, 1986

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.